ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0870

Knee Acoustic Emissions as a Noninvasive Biomarker of Articular Health in Juvenile Idiopathic Arthritis

Sevda Gharehbaghi1, Emily Moise1, Priya Brito2, Lori Ponder3, Omer Inan1 and Sampath Prahalad4, 1Georgia Institute of Technology, Atlanta, GA, 2Emory University, Atlanta, GA, 3Children's Healthcare of Atlanta, Atlanta, GA, 4Emory + Children's Pediatric Institute, Atlanta, GA

Meeting: ACR Convergence 2022

Keywords: Biomarkers, Juvenile idiopathic arthritis, Juvenile Rheumatoid Arthritis, Measurement, Statistical methods

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Pediatric Rheumatology – Clinical Poster I: JIA

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Juvenile idiopathic arthritis (JIA) refers to all forms of autoimmune arthritis in children with undetermined etiology, and thus it is the most prevalent chronic arthritis in children. Hallmark symptoms of JIA include swelling, warmth, pain, and stiffness in the joints, particularly in the knee, the most commonly affected joint. For clinical trials, a joint with either swelling alone, and/or tenderness, and limited motion is considered active. The chronic inflammation of the joint causes damage to the smooth and slippery underlying cartilage and even bone if left untreated. Current diagnostic methods involve insensitive and subjective physician examinations, general symptom-based patient surveys, and non-specific laboratory tests. Crepitus emitted from inter-joint articulating surfaces, aka joint acoustic emissions (JAEs), can be recorded with highly sensitive contact microphones and used as a non-invasive biomarker of articular health in children with JIA, allowing differentiation between healthy and arthritic joints and particularly active and inactive involvement.

Methods: Knee JAEs were acquired from 117 participants while subjects were asked to perform 10 repetitions of seated knee flexion/extensions. Study participants included 30 healthy controls and 87 subjects with JIA where 43 knees had active JIA involvement and 131 knees had inactive JIA involvement. These JAE signals were filtered, denoised, and then divided into short-time frames to extract 273 time-frequency audio features, from which 60 top Principal Components (PC), explaining 95% of the data variance, were obtained as the training data for an Extreme Gradient Boosting (XGBoost) machine learning classification model. Knees with active JIA involvement were assumed to have more certain labels compared to inactive cases. Therefore, the classifier was trained on all knees with active JIA and 80% of the healthy controls and then tested on the knees with inactive JIA and the rest of the healthy controls. The classifier predicted a knee health score for each leg as the probability of having JIA.

Results: The classifier was validated on the training data through a leave-one-leg-out cross-validation with 81% accuracy. Then, it was tested on the knees with inactive JIA involvement and remaining healthy knees, resulting in 87% accuracy. The validation and test confusion matrices are shown in Fig. 1 (a–b). The health score distribution of knees with active involvement was significantly higher than those with inactive involvement (Fig. 1 (d)). Furthermore, from 27 subjects with unilateral knee involvement, 70% of the active knees were correctly assigned to a higher JIA probability compared to inactive knees.

Conclusion: This study obtains knee JAEs from a larger population compared to our previous study and it demonstrates a more generalizable model for knee health assessment in children with JIA. Therefore, it supports the use of JAEs as a novel non-invasive digital biomarker for Articular Health assessment. Furthermore, knee health scores can differentiate between active and inactive JIA and can be used to better personalize the treatment.

Supporting image 1

Results of classification, including the confusion matrix of leave-one-leg-out validation on the training data (a) and testing data (b), receiver operating characteristic (ROC) curve of the classifier (c), and the density distribution of the scores from active and inactive legs of subjects with asymmetric JIA involvement.


Disclosures: S. Gharehbaghi, None; E. Moise, None; P. Brito, None; L. Ponder, None; O. Inan, Arthroba; S. Prahalad, Novartis.

To cite this abstract in AMA style:

Gharehbaghi S, Moise E, Brito P, Ponder L, Inan O, Prahalad S. Knee Acoustic Emissions as a Noninvasive Biomarker of Articular Health in Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/knee-acoustic-emissions-as-a-noninvasive-biomarker-of-articular-health-in-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/knee-acoustic-emissions-as-a-noninvasive-biomarker-of-articular-health-in-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology